Endothelial dysfunction and long-term survival in cardiovascular-kidney-metabolic syndrome stages 0-3: An EASIX-based national cohort study
Science Progress
Cite this paper
Plain citation
Asiya Abudesimu, Zhonghua Sun, Ge Zhang, Xiangyu Sun, Xinliang Peng, Dilixiati Siti, Xiang Ma. Endothelial dysfunction and long-term survival in cardiovascular-kidney-metabolic syndrome stages 0-3: An EASIX-based national cohort study. Science Progress. 2026;109(4):00368504261499186. https://doi.org/10.1177/00368504261499186
Author evidence note
Research question and design
The study examined whether EASIX was associated with later mortality among 10,885 NHANES participants aged at least 30 years with cardiovascular-kidney-metabolic syndrome stages 0–3. It retrospectively analyzed survey cycles from 1999–2018, linking deaths through 2019. EASIX is calculated as lactate dehydrogenase multiplied by creatinine, divided by platelet count.
Principal quantitative findings
Over a median 97 months of follow-up, 1,122 participants died; 295 deaths were cardiovascular. Per one-unit higher EASIX, the adjusted hazard ratio was 1.41 (95% CI 1.24–1.61) for all-cause mortality and 1.30 (95% CI 1.13–1.49) for cardiovascular mortality. The abstract reports that the associations persisted after further lifestyle adjustment.
Cohort and model specification
Eligibility required a valid fasting-subsample weight and complete CKM-staging, EASIX, mortality-linkage and covariate information; participants were assigned their highest qualifying CKM stage, and stage 4 was excluded. Stage 3 included very-high-risk CKD or PREVENT 10-year total-CVD risk ≥20%; participants aged ≥80 years were assigned age 79 for PREVENT estimation. EASIX used LDH (U/L) × creatinine (mg/dL) / platelet count (10^9/L) and was modeled per one-unit increase and by quartiles. Analyses combined fasting-subsample weights with SDMVSTRA and SDMVPSU in survey-weighted Cox models. Model 2 added current smoking, BMI, systolic blood pressure, fasting glucose and antihypertensive, glucose-lowering and statin use to demographic adjustment. Follow-up ran from the baseline MEC examination to death or 31 December 2019; competing-risk analysis was a sensitivity analysis. These specifications support comparing cohort and model choices; the displayed Methods do not give the pooled-weight formula or exact cardiovascular-death codes.
Scientific contribution and publication context
The analysis connects a composite endothelial-stress index with long-term outcomes among adults at CKM stages 0–3. It provides an observational comparator for epidemiologic discussions of endothelial stress, CKM staging and mortality; survey-weighted Cox models and spline analyses supply the reported association framework. Clinical risk-assessment use requires further validation. Electronic publication is recorded as 18 October 2026. The formal journal record is Science Progress, volume 109, issue 4 (2026), article 00368504261499186.
Evidence scope and limitations
Author-maintained explanation of an observational mortality analysis in CKM stages 0–3, supported by the indexed abstract and source-located reading of the published Methods.
- The retrospective cohort associations support epidemiologic comparison; they do not establish that changing EASIX changes mortality or that EASIX is an externally validated clinical prediction model.
Provenance
- Indexed cohort-study abstract and author metadata — PubMed XML abstract and bibliographic metadata; original paraphrase above. PMID 42893432, Abstract Objective/Methods/Results/Conclusions, AuthorList and ArticleDate.
- Publisher-deposited citation record — Crossref bibliographic metadata. DOI 10.1177/00368504261499186, volume, issue, article-number and publication dates.
- Published article text and Methods on ResearchGate — Published article text displayed publicly on ResearchGate; source-located Methods reading. The article frontmatter states CC BY-NC 4.0.. Same DOI and PMID; Materials and Methods Sections 2.1–2.5; original article license notice.
Source review: 2026-11-15.